Johanna Mercier - 17 Nov 2025 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chief Commercial Officer
Signature
/s/ Edward S. Son by Power of Attorney for Johanna Mercier
Issuer symbol
GILD
Transactions as of
17 Nov 2025
Net transactions value
-$1,858,173
Form type
4
Filing time
18 Nov 2025, 18:51:51 UTC
Previous filing
16 Oct 2025
Next filing
11 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mercier Johanna Chief Commercial Officer GILEAD SCIENCES, INC., 333 LAKESIDE DRIVE, FOSTER CITY /s/ Edward S. Son by Power of Attorney for Johanna Mercier 18 Nov 2025 0001782135

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise $1,666,000 +25,000 +23% $66.64 135,193 17 Nov 2025 Direct F1
transaction GILD Common Stock Sale $3,211,560 -25,524 -19% $125.83 109,669 17 Nov 2025 Direct F1, F2
transaction GILD Common Stock Sale $312,614 -2,476 -2.3% $126.26 107,193 17 Nov 2025 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Non-qualified Stock Option (Right to Buy) Options Exercise $0 -25,000 -25% $0.000000 73,110 17 Nov 2025 Common Stock 25,000 $66.64 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
F2 Sales prices for the transactions reported here range from $125.23 to $126.20. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F3 Sales prices for the transactions reported here range from $126.23 to $126.39. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F4 The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.